HIKMA PHARMS FDA Approval ANDA 203824

ANDA 203824

HIKMA PHARMS

FDA Drug Application

Application #203824

Application Sponsors

ANDA 203824HIKMA PHARMS

Marketing Status

Prescription001

Application Products

001TABLET;ORAL875MG;EQ 125MG BASE0AMOXICILLIN AND CLAVULANATE POTASSIUMAMOXICILLIN; CLAVULANATE POTASSIUM

FDA Submissions

UNKNOWN; ORIG1AP2016-08-23

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

HIKMA PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203824
            [companyName] => HIKMA PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"AMOXICILLIN AND CLAVULANATE POTASSIUM","activeIngredients":"AMOXICILLIN; CLAVULANATE POTASSIUM","strength":"875MG;EQ 125MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/23\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"08\/23\/2016","submission":"SUPPL-1","supplementCategories":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2016-08-23
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.